These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA. Nishino T, Yamauchi T, Horie M, Nagumo T, Suzuki H. Thromb Res; 2000 Sep 15; 99(6):623-34. PubMed ID: 10974349 [Abstract] [Full Text] [Related]
6. Mechanism of the stimulatory effect of native fucoidan, highly sulfated fucoidan and heparin on plasminogen activation by tissue plasminogen activator: the role of chloride. Lang D, Williams T, Phillips A, Doctor VM. Eur J Drug Metab Pharmacokinet; 2004 Sep 15; 29(4):269-75. PubMed ID: 15726889 [Abstract] [Full Text] [Related]
7. Differences in the activation rates of plasminogen by tissue plasminogen activator and urokinase. Takada A, Shizume K, Cho M, Takada Y. Thromb Res; 1987 Feb 15; 45(4):371-81. PubMed ID: 2437668 [Abstract] [Full Text] [Related]
8. Activation of Val442-plasminogen (mini-plasminogen) by urokinase, streptokinase and tissue plasminogen activator. Takada A, Takada Y, Sugawara Y. Thromb Res; 1988 Jan 15; 49(2):253-63. PubMed ID: 3129817 [Abstract] [Full Text] [Related]
9. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator. Watahiki Y, Scully MF, Ellis V, Kakkar VV. Thromb Haemost; 1989 Jun 30; 61(3):502-6. PubMed ID: 2508259 [Abstract] [Full Text] [Related]
10. Effect of fucoidan during activation of human plasminogen. Doctor VM, Hill C, Jackson GJ. Thromb Res; 1995 Aug 01; 79(3):237-47. PubMed ID: 8533120 [Abstract] [Full Text] [Related]
11. Importance of GlcUAbeta1-3GalNAc(4S,6S) in chondroitin sulfate E for t-PA- and u-PA-mediated Glu-plasminogen activation. Sakai T, Kyogashima M, Kariya Y, Urano T, Takada Y, Takada A. Thromb Res; 2000 Dec 15; 100(6):557-65. PubMed ID: 11152936 [Abstract] [Full Text] [Related]
12. Mechanism of the stimulatory effect of 6-aminohexanoic acid on plasminogen activation by streptokinase or tissue plasminogen activator: the role of chloride. Guinn L, Doctor VM. Eur J Drug Metab Pharmacokinet; 2003 Dec 15; 28(4):315-20. PubMed ID: 14743974 [Abstract] [Full Text] [Related]
13. Conformational change of plasminogen: effects of N-terminal peptides of Glu-plasminogen. Takada Y, Urano T, Takada A. Thromb Res; 1993 Apr 15; 70(2):151-9. PubMed ID: 8391730 [Abstract] [Full Text] [Related]
14. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators. Castañon MM, Gamba C, Kordich LC. Thromb Res; 2007 Apr 15; 120(5):745-52. PubMed ID: 17270255 [Abstract] [Full Text] [Related]
16. Autoradiographic and immunoblotting analyses of the activation pathways of plasminogen by urokinase and tissue plasminogen activator in the plasma or clotted plasma. Takada A, Yoshida M, Takada Y. Thromb Res; 1988 Jan 15; 49(2):193-204. PubMed ID: 3129815 [Abstract] [Full Text] [Related]
18. Effect of oversulfation on the chemical and biological properties of chondroitin-4-sulfate. Carranza YE, Durand-Rougley C, Doctor V. Blood Coagul Fibrinolysis; 2008 Sep 15; 19(6):483-7. PubMed ID: 18685430 [Abstract] [Full Text] [Related]
19. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system. Ries M, Zenker M, Gaffney PJ. Thromb Res; 2000 Nov 15; 100(4):341-51. PubMed ID: 11113278 [Abstract] [Full Text] [Related]